Suchergebnisse - "Vessela N Kristensen"

PubPharm (36)

1

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.

in: PLoS ONE | 2023

von Lisa Svartdal Normann | Mads Haugland Haugen | Vesa Hongisto | +7

2

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

in: Genome Medicine | 2023

von Stefanie H. Mueller | Alvina G. Lai | Maria Valkovskaya | +180

3

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

in: Cancers | 2023

von Torgeir Mo | Siri Helene Bertelsen Brandal | Oliver Marcel Geier | +7

4

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

in: Cancer Medicine | 2023

von Anna Morra | Maartje A. C. Schreurs | Irene L. Andrulis | +117

5

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

in: Breast Cancer Research | 2022

von Thomas U. Ahearn | Haoyu Zhang | Kyriaki Michailidou | +159

6

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

in: Breast Cancer Research | 2022

von Christine Aaserød Pedersen | Maria Dung Cao | Thomas Fleischer | +9

7

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

in: Breast Cancer Research | 2022

von Hongjie Chen | Shaoqi Fan | Jennifer Stone | +54

8

Breast cancer risks associated with missense variants in breast cancer susceptibility genes

in: Genome Medicine | 2022

von Leila Dorling | Sara Carvalho | Jamie Allen | +106

9

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3 VNTR polymorphisms and gene co-expression

in: npj Breast Cancer | 2021

von Jaume Fores-Martos | Raimundo Cervera-Vidal | Julia Sierra-Roca | +16

10

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

in: Scientific Reports | 2021

von Lisa Svartdal Normann | Miriam Ragle Aure | Suvi-Katri Leivonen | +5